Cargando…

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

BACKGROUND: Pulmonary hypertension (PH) remains a prevalent disease globally. Sodium tanshinone II sulfonate A (STS) has been used in clinical treatment of PH. AIMS: The aim of the present study was to investigate the effect of sodium STS treatment on hypoxia-induced PH and related mechanisms. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Ya-Ru, Chen, Jing-Wei, Jiang, Yan, Wang, Lin-Hui, Xue, Rong, Qian, Jin-Xian, Zhang, Guo-Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253651/ https://www.ncbi.nlm.nih.gov/pubmed/32508639 http://dx.doi.org/10.3389/fphar.2020.00687

Ejemplares similares

Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Xu, Junyao, et al.
Publicado: (2019)

Sodium Tanshinone II-A Sulfonate (DS-201) Induces Vasorelaxation of Rat Mesenteric Arteries via Inhibition of L-Type Ca(2+) Channel
por: Zhang, Xiao-Dong, et al.
Publicado: (2018)

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
por: Zhou, Zhong-Yan, et al.
Publicado: (2020)

Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice
por: Yang, Xin-Jing, et al.
Publicado: (2018)

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
por: Mao, Shuai, et al.
Publicado: (2019)

Sodium tanshinone IIA sulfonate ameliorates cerebral ischemic injury through regulation of angiogenesis
por: Xu, Jiazhen, et al.
Publicado: (2021)

Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway
por: Guan, Ruijuan, et al.
Publicado: (2018)

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice
por: Heng, Yan-Yan, et al.
Publicado: (2023)

Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats
por: Pan, Yun, et al.
Publicado: (2017)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
por: Zhang, Rongjie, et al.
Publicado: (2022)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Sodium Tanshinone IIA Sulfonate Attenuates Tumor Oxidative Stress and Promotes Apoptosis in an Intermittent Hypoxia Mouse Model
por: Zhang, Xiao-Bin, et al.
Publicado: (2020)

Sodium tanshinone IIA sulfonate stimulated Cl(−) secretion in mouse trachea
por: Chen, Peng-Xiao, et al.
Publicado: (2017)

Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia
por: Zhong, Liren, et al.
Publicado: (2020)

Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II-Induced Differentiation of Human Atrial Fibroblasts into Myofibroblasts
por: Chen, Tangting, et al.
Publicado: (2018)

Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro
por: Ouyang, Dong-sheng, et al.
Publicado: (2016)

Corrigendum to “Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia”
por: Zhong, Liren, et al.
Publicado: (2020)

Sodium Tanshinone IIA Sulfonate Ameliorates Injury-Induced Oxidative Stress and Intervertebral Disc Degeneration in Rats by Inhibiting p38 MAPK Signaling Pathway
por: Dai, Shouqian, et al.
Publicado: (2021)

Sodium Tanshinone IIA Sulfonate Improves Hemodynamic Parameters, Cytokine Release, and Multi-Organ Damage in Endotoxemia Rabbits
por: Ma, Shaolei, et al.
Publicado: (2018)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
por: Kan, Zunqi, et al.
Publicado: (2023)

The mechanisms of tanshinone in the treatment of tumors
por: Zhang, Pengyu, et al.
Publicado: (2023)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
por: Zheng, Yanfang, et al.
Publicado: (2022)

Tanshinone II-A sodium sulfonate (DS-201) enhances human BK(Ca) channel activity by selectively targeting the pore-forming α subunit
por: Tan, Xiao-qiu, et al.
Publicado: (2014)

Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension
por: He, Yang-Yang, et al.
Publicado: (2021)

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage
por: Ji, Biying, et al.
Publicado: (2017)

The efficacy and safety of sodium tanshinone ⅡA sulfonate injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis
por: Wu, Xiaoqi, et al.
Publicado: (2023)

Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model
por: Lu, Lunjie, et al.
Publicado: (2016)

Sodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic System
por: Xu, Qing-Qing, et al.
Publicado: (2016)

Sodium Tanshinone IIA Sulfonate Prevents Radiation-Induced Toxicity in H9c2 Cardiomyocytes
por: Zhang, Wenjing, et al.
Publicado: (2017)

Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn
por: Wedgwood, Stephen, et al.
Publicado: (2015)

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension
por: He, Yang-Yang, et al.
Publicado: (2021)

Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza
por: Jiang, Zhouqian, et al.
Publicado: (2019)

Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation
por: Jiang, Xiaoxiao, et al.
Publicado: (2015)

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)

Sodium tanshinone IIA sulfonate protects ARPE-19 cells against oxidative stress by inhibiting autophagy and apoptosis
por: Han, Dongmei, et al.
Publicado: (2018)

Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis
por: Zhu, Ji, et al.
Publicado: (2022)

Sishen Wan(®) Ameliorated Trinitrobenzene-Sulfonic-Acid-Induced Chronic Colitis via NEMO/NLK Signaling Pathway
por: Wang, Hai-Yan, et al.
Publicado: (2019)

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
por: Fu, Li, et al.
Publicado: (2020)

Recent advances of tanshinone in regulating autophagy for medicinal research
por: Wu, Sha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ij0du9vhp4lma7sno15etmqjg6